- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Idiopathic Pulmonary Fibrosis in New Zealand
Total 1918 results
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisSpain, Denmark, United Kingdom, New Zealand
-
National Jewish HealthYale University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Baylor University and other collaboratorsActive, not recruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Bristol-Myers SquibbCompletedHealthy Participants | Idiopathic Pulmonary Fibrosis (IPF)United States
-
BiogenCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
NYU Langone HealthStony Brook University; National Center for Research Resources (NCRR); Philips...CompletedPulmonary FibrosisUnited States
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
NYU Langone HealthWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Russian Federation, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
HuniLife Biotechnology, Inc.RecruitingIdiopathic Pulmonary FibrosisTaiwan
-
Pulmonary Fibrosis FoundationUniversity of MichiganCompletedInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Germany
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
Hal ChapmanMassachusetts General Hospital; University of Michigan; University of Washington and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; University... and other collaboratorsTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
University of Alabama at BirminghamUniversity of Michigan; Tulane University; Temple UniversityRecruitingIdiopathic Pulmonary FibrosisUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Weill... and other collaboratorsCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseUnited States
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Boehringer IngelheimActive, not recruiting
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Cumberland PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, United Kingdom, Israel, Argentina, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
Boehringer IngelheimTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
BayerTerminatedIdiopathic Interstitial Pneumonias / Hypertension,PulmonaryBelgium, Israel, Spain, United States, Switzerland, New Zealand, Greece, Portugal, Japan, Argentina, Canada, Denmark, France, Germany, Russian Federation, Turkey, Colombia, Saudi Arabia, Australia, Italy, United Kingdom
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
SanofiCompletedIdiopathic Pulmonary FibrosisCzechia, Korea, Republic of, Mexico, Israel, Spain, Greece, Chile, Canada, Colombia, Turkey, Denmark, France, United States, Argentina, Australia, Germany, Italy, Portugal, United Kingdom
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); PfizerCompletedPulmonary Fibrosis | Hypertension, PulmonaryUnited States
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
Hoffmann-La RocheCompleted
-
Toray Industries, IncCompletedIdiopathic Pulmonary FibrosisUnited States